Today: 17 June 2026

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Dueling Dinosaurs Fossil Shocks Scientists: ‘Teenage T. rex’ Was a New Species All Along

Dueling Dinosaurs Fossil Shocks Scientists: ‘Teenage T. rex’ Was a New Species All Along

Researchers confirmed Nanotyrannus was a distinct tyrannosaur species that lived alongside T. rex, not a juvenile T. rex, after analyzing the “Dueling Dinosaurs” fossil. The study identified two Nanotyrannus species, both smaller and anatomically different from T. rex. Findings overturn decades of assumptions about young T. rex fossils and force a reexamination of tyrannosaur evolution.
31 October 2025
Jack’s Donuts Bankruptcy Shakes Indiana – 64-Year-Old Doughnut Chain Faces Uncertain Future

Jack’s Donuts Bankruptcy Shakes Indiana – 64-Year-Old Doughnut Chain Faces Uncertain Future

Jack’s Donuts of Indiana Commissary, LLC filed for Chapter 11 bankruptcy on Oct. 29, 2025, listing $14.2 million in liabilities and $1.4 million in assets. Franchise locations remain open and are not affected by the filing. The bankruptcy follows a failed expansion into centralized production and legal action against CEO Lee Marcum for alleged securities violations. Marcum’s other companies also filed for bankruptcy the same day.
31 October 2025
·
Vivakor (VIVK) Stock Skyrockets on Oil Deal and Trading Debut – Will the Rally Last?

Vivakor (VIVK) Stock Skyrockets on Oil Deal and Trading Debut – Will the Rally Last?

Vivakor shares surged nearly 20% to $0.32 intraday on October 30, 2025, after announcing a $24 million Permian Basin crude oil deal and securing a $40 million credit facility. The Dallas firm also raised $3.5 million in new equity and saw its lender convert $1.45 million of debt into shares, diluting existing holders. VIVK trades below Nasdaq’s $1 minimum and posted a $22 million loss in 2024.
30 October 2025
··
Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Cardinal Health shares jumped 13% to record highs near $185 after fiscal Q1 2026 results beat estimates, with adjusted EPS at $2.55 and revenue at $64.0 billion. The company raised its full-year outlook and announced a $375 million buyback. All five segments grew profits, marking an eighth straight earnings beat. Cardinal plans to close the Solaris Health acquisition by early November.
30 October 2025
··
Apellis’ $458M Shocker: FDA Win, Analyst Buzz & 20% Stock Whiplash

Apellis’ $458M Shocker: FDA Win, Analyst Buzz & 20% Stock Whiplash

Apellis Pharmaceuticals reported Q3 2025 revenue of $458.6 million and a $215.7 million net profit, but its stock fell about 21% after management warned of future losses. Syfovre sales in the U.S. were flat at $150.9 million, with modest injection growth and ongoing debate over its benefits. Empaveli gained FDA approval for rare kidney diseases in July. Analyst ratings and price targets remain divided.
30 October 2025
·
Perimeter Solutions (PRM) Stock Soars on Earnings Beat and New Firefighting Deal

Perimeter Solutions (PRM) Stock Soars on Earnings Beat and New Firefighting Deal

Perimeter Solutions (NYSE: PRM) shares surged over 25% on October 30, 2025 after the company reported Q3 revenue of $315.4 million, beating estimates, and announced a major U.S. Forest Service contract renewal. Adjusted EPS reached $0.82, a 49% surprise. PRM stock has gained about 67% year-to-date, nearing a 52-week high around $24.85. Analysts rate the stock a “Buy” with an average price target of $26.
30 October 2025
·
Cleveland-Cliffs’ Rollercoaster: CLF Stock Soars on Rare-Earth Hype, Plunges on Share Sale – What’s Next?

Cleveland-Cliffs’ Rollercoaster: CLF Stock Soars on Rare-Earth Hype, Plunges on Share Sale – What’s Next?

Cleveland-Cliffs shares fell about 12% to the low-$12 range on Oct. 30, 2025, after announcing a 75 million share offering to raise $964 million, sparking dilution concerns. The drop followed a surge to a 52-week high above $16 on strong Q3 results and rare-earth minerals news. Q3 revenue rose 3.6% to $4.73 billion, with an adjusted net loss of $0.45 per share. Wall Street’s consensus price target remains below recent trading levels.
30 October 2025
·
C.H. Robinson Stock Skyrockets 20% to Record High on AI-Fueled Profit Beat and Raised Outlook

C.H. Robinson Stock Skyrockets 20% to Record High on AI-Fueled Profit Beat and Raised Outlook

C.H. Robinson shares jumped over 20% to a record high after third-quarter earnings beat forecasts, with adjusted EPS at $1.40 versus $1.30 expected. Revenue dropped 10.9%, but profit rose on cost cuts and AI gains. Management raised its 2026 operating income target by $50 million and approved a $2 billion buyback. Analysts lifted price targets, citing operational changes and tech investments.
30 October 2025
···
ServiceNow (NOW) Surges on Blowout Q3 Earnings and 5-for-1 Stock Split Amid AI Boom

ServiceNow (NOW) Surges on Blowout Q3 Earnings and 5-for-1 Stock Split Amid AI Boom

ServiceNow shares jumped nearly 4% to around $950 by midday Oct. 30 after Q3 results beat forecasts, with subscription revenue up 21.5% to $3.30 billion and adjusted EPS at $4.82. The company announced a 5-for-1 stock split pending December approval and raised its full-year outlook. Wall Street remains bullish, with most analysts rating the stock a buy and price targets up to $1,300.
30 October 2025
···
eBay Stock Soars on Earnings Beat, Stumbles on Weak Holiday Outlook

eBay Stock Soars on Earnings Beat, Stumbles on Weak Holiday Outlook

eBay shares surged to a 52-week high above $101 after Q3 2025 earnings beat estimates, with revenue up 9% to $2.82 billion and EPS at $1.36. The stock dropped 7–9% in after-hours trading on Oct. 29 after executives issued a weaker-than-expected holiday profit forecast, citing macro pressures and new tariffs. Year-to-date, eBay is up about 60%. Analyst targets remain split, with the average in the low $90s.
30 October 2025
··
OpenAI’s $500B Overhaul Rocks Tech World: Microsoft Snags $135B Stake and AI ‘Arms Race’ Ignites

OpenAI’s $500B Overhaul Rocks Tech World: Microsoft Snags $135B Stake and AI ‘Arms Race’ Ignites

OpenAI has completed a major recapitalization, with its nonprofit foundation retaining 26% of the for-profit arm, valued at about $130 billion. Microsoft’s stake drops to 27% but gains exclusive model rights and Azure access through 2032, while OpenAI commits to spend $250 billion on Azure. The new structure allows OpenAI to partner beyond Microsoft. Microsoft stock rose 4% on the news.
30 October 2025
··
Quantum Breakthrough or Bubble? Rigetti Stock Rockets 5,000% in 2025

Quantum Breakthrough or Bubble? Rigetti Stock Rockets 5,000% in 2025

Rigetti Computing shares soared nearly 5,000% in 2025, peaking at $56 in mid-October before dropping to the high $30s. The company won a $5.8 million U.S. Air Force contract and launched a 36-qubit processor, but Q2 revenue was just $1.8 million against a $39.7 million net loss. Market cap reached $12–17 billion, drawing analyst warnings of overvaluation. U.S. policy speculation fueled further volatility.
30 October 2025
··
Denison Mines (DNN) Soars on Uranium Boom – How High Can It Go?

Denison Mines (DNN) Soars on Uranium Boom – How High Can It Go?

Denison Mines shares (DNN) closed at about $3.17 on Oct. 29, more than double their price at the start of 2025, amid a uranium market rally and multiyear-high prices. All five analysts covering DNN rate it “Buy/Outperform,” with targets ranging from C$2.75 to C$5.00. Denison’s Wheeler River project cleared provincial approval in August and awaits federal licensing. The company’s McClean Lake JV resumed production in mid-2025.
30 October 2025
·
Pfizer Stock Soars: Trump’s Drug-Price Deal and $7B Weight-Loss Bet Spark Rally

Pfizer Stock Soars: Trump’s Drug-Price Deal and $7B Weight-Loss Bet Spark Rally

Pfizer shares traded near $24.20 on Oct. 30, 2025, flat for the week and close to the low end of their 52-week range. The stock surged 15% in late September after Pfizer agreed to cut Medicaid drug prices and announced a $7.3 billion deal to acquire obesity-drug maker Metsera. Rival Novo Nordisk countered with a higher bid for Metsera. Q3 earnings are due Nov. 4, with analysts expecting a sharp year-over-year decline.
30 October 2025
··
SoFi Stock Rockets 230% in 2025 on Record Q3 and Fintech Boom

SoFi Stock Rockets 230% in 2025 on Record Q3 and Fintech Boom

SoFi shares surged 230% year-over-year, closing at $31.66 after Q3 earnings on Oct. 28 before slipping to around $29.90 by Oct. 30. The company beat Q3 forecasts with $950 million in adjusted net revenue and raised its 2025 guidance. Analysts remain split, with targets ranging from $18 to $36. Cathie Wood’s ARK Invest doubled its stake last quarter, while institutional ownership stands near 48%.
30 October 2025
···
Lyzr Raises $8M and Lands Accenture’s AI Backing – Is “Agentic AI” About to Explode?

Lyzr Raises $8M and Lands Accenture’s AI Backing – Is “Agentic AI” About to Explode?

Lyzr closed an $8 million Series A funding round on Oct. 29, 2025, led by Rocketship.vc, with Accenture Ventures and others participating. The company claims over 1 billion AI agent simulations run and more than 1 million agents in production, mainly for financial-sector clients. Accenture also announced a strategic minority investment and partnership with Lyzr. Lyzr reported about $1.5 million in annual recurring revenue.
30 October 2025
····
1 … 61 62 63 64 65 … 148

Stock Market Today

  • ERock Simplifies Equity Structure and Adds Independent Board After IPO
    June 16, 2026, 9:15 PM EDT. ERock (NYSE:EROC) completed its IPO, raising capital to support its power systems business. The company simplified its equity structure through repurchases and restructuring, adopting new bylaws and a revised certificate of incorporation. It established a new independent board with defined committee roles, aiming to strengthen governance. ERock trades at $15.30 with no analyst price targets yet and is flagged as undervalued by one estimate, trading nearly 96% below fair value. Investors should monitor how the board manages IPO proceeds against current revenue of $190.8 million and a net loss of $68.2 million. Shares are highly illiquid, possibly causing wider spreads and price volatility. These changes offer a clearer foundation for public oversight as ERock transitions to a public company.

Latest articles

Dow Closes at Record in After-Hours as S&P 500, Nasdaq Dip on Tech Slide

Dow Closes at Record in After-Hours as S&P 500, Nasdaq Dip on Tech Slide

17 June 2026
Dow hits second straight record close at 51,999.67 while S&P 500 and Nasdaq drop as tech stocks slide; Philadelphia semiconductor index plunges 5.7% and after-hours trading sees only slight gains for major index-tracking funds, as investors brace for Wednesday’s Fed decision and monitor inflation risks amid falling oil prices and a possible U.S.-Iran deal.
GD Culture shares drop on heavy trading and ongoing buyout uncertainty

GD Culture shares drop on heavy trading and ongoing buyout uncertainty

17 June 2026
GD Culture Group plunged 73.3% to $0.028 after heavy trading, putting fresh pressure on its unresolved, non-binding $10.75-per-share buyout proposal; risks include deal uncertainty, a $300 million share-sale program, and bitcoin-driven balance sheet swings, with no new company updates released Tuesday.
Go toTop